Efficacy and tolerability of second- and third-generation antihistamines in the treatment of acquired cold urticaria: a meta-analysis.

[1]  T. Zuberbier,et al.  High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. , 2009, The Journal of allergy and clinical immunology.

[2]  T. Zuberbier,et al.  Acquired cold urticaria symptoms can be safely prevented by ebastine , 2007, Allergy.

[3]  A. Wanderer.  Cold temperature challenges for acquired cold urticaria. , 2005, Journal of Allergy and Clinical Immunology.

[4]  H. Hoffman,et al.  The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. , 2004, Immunology and allergy clinics of North America.

[5]  L. Juhlin.  Inhibition of cold urticaria by desloratadine , 2004, The Journal of dermatological treatment.

[6]  U. Kiistala,et al.  Suction blister device with regulation of temperature: Demonstration of histamine release and temperature change in cold urticaria , 2004, Archives of Dermatological Research.

[7]  G. Canonica,et al.  Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. , 2003, Journal of the American Academy of Dermatology.

[8]  L. Dubertret,et al.  Mizolastine in primary acquired cold urticaria. , 2003, Journal of the American Academy of Dermatology.

[9]  B. Henz.  The pharmacologic profile of desloratadine: a review , 2001, Allergy.

[10]  Joint Task Force on Practice Parameters.  The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Joint Task Force on Practice Parameters. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  C. Spencer,et al.  Ebastine , 2000, Drugs.

[12]  A. Wanderer.  Cold urticaria syndromes: historical background, diagnostic classification, clinical and laboratory characteristics, pathogenesis, and management. , 1990, The Journal of allergy and clinical immunology.

[13]  J. R. Gibson,et al.  Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria. , 1988, Dermatologica.

[14]  T. Malm,et al.  Aortocoronary bypass surgery with normothermia in a patient with severe cold urticaria. , 1988, The Thoracic and cardiovascular surgeon.

[15]  C. De Vos,et al.  Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares, experimental dermographism, and cold-induced urticaria. , 1987, The Journal of allergy and clinical immunology.

[16]  R. Farr,et al.  Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. , 1986, The Journal of allergy and clinical immunology.

[17]  H. Neittaanmäki,et al.  Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria: usefulness of doxepin. , 1984, Journal of the American Academy of Dermatology.

[18]  J. Barth,et al.  An assessment of the novel antihistamine BW 825C in the treatment of chronic idiopathic urticaria. A placebo-controlled study. , 1984, Dermatologica.

[19]  D. Wallach,et al.  Immunological findings in two cases of subcorneal pustular dermatosis , 1983 .

[20]  A. Black,et al.  Histamine and the skin. , 1983, British Journal of Dermatology.

[21]  A. Kaplan,et al.  Assessment of tissue fluid histamine levels in patients with urticaria. , 1978, The Journal of allergy and clinical immunology.

[22]  E. Ellis,et al.  Primary acquired cold urticaria. Double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. , 1977, Archives of dermatology.

[23]  E. Ellis,et al.  Treatment of cold urticaria with cyproheptadine. , 1971, The Journal of allergy and clinical immunology.